Skip to content

Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)

A Randomized Controlled Trial Comparing Modular Dual Mobility Inserts With Ceramic Multilayer Coating Versus Standard Polyethylene Inserts for Primary Total Hip Arthroplasty (THA) in a Cementless Acetabular Cup

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05547984
Acronym
CeMoD-prime
Enrollment
100
Registered
2022-09-21
Start date
2022-11-21
Completion date
2028-08-31
Last updated
2025-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coxarthrosis; Primary

Keywords

Dual Mobility Cup, Total Hip Arthroplasty

Brief summary

A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cup

Detailed description

The aim of this study is to show in a randomized controlled trial that cobalt and chromium ion serum levels are comparable to the metal ion levels in patients with standard articulation with metal head. The metal on polyethylene articulation is accepted as standard articulation since many decades, and which is currently in the Czech Republic the most used combination. Most studies which focused on the topic of metal ion release from modular dual mobility systems do not present results of a control group with standard articulation hip implants.

Interventions

Total hip arthroplasty (THA) is a successful and established therapy for coxarthrosis, rheumatic arthritis, hip fractures and femoral head necrosis. The acetabular implant for this arm is the Dual Mobility cup

DEVICEStandard Acetabular component

Total hip arthroplasty (THA) is a successful and established therapy for coxarthrosis, rheumatic arthritis, hip fractures and femoral head necrosis. The acetabular implant for this arm is the standard device with polyethylene + vitamin E inlay and metal head

Sponsors

Aesculap AG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Primary coxarthrosis patients indicated for cementless total hip arthroplasty * Written informed patient consent

Exclusion criteria

* Hip trauma or revision surgery * Rheumatoid or neurologic disease * BMI \>35 * Ongoing oncologic therapy * Preoperatively elevated Co or Cr serum levels \>1.0 µg/L * Patients with other joint implants, or anticipated need for another joint replacement surgery within the study period * Acetabular cup size \<52 expected * Patients not able to mentally or physically comply with the study demands and follow-up visits * Patients \<18 years at surgery * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Serum metal ion analysis (Cobalt)12 months after surgeryCobalt ion levels in blood serum in measured in \[µg/L\], Comparison between the two groups
Serum metal ion analysis (Chromium)12 months after surgeryChromium ion levels in blood serum in measured in \[µg/L\], Comparison between the two groups

Secondary

MeasureTime frameDescription
Change of functional outcome over three year follow-up period (Harris Hip Score)3 months, 12 months and 3 years postoperativelyThe Harris Hip Score (HHS) is one of the most used scores in total hip arthroplasty, mainly combining range of motion questions with questions regarding daily life activities. The HHS is a measure of dysfunction so the higher the score, the better the outcome for the individual. Results can be recorded and calculated online. The maximum score possible is 100, any result \<70 is considered a poor result; The HHS is an outcome measure administered by a qualified health care professional, such as a physician or a physical therapist.
Gait analysis over timepreoperative, 3 months and 12 months postoperativelyThe gait lab analysis involves a high amount of recorded data and variables. Gait lab analyses are performed with the patients between the preoperative state, 3 months after surgery and 1 year postoperative. The Gait Profile Score (GPS) is used as a measure for the deviation in gait kinematics from a healthy patient population to compare the two treatment groups. Lower score values can be considered as a sign of better restoration of the physiological gait kinematics.
Development of Patient satisfaction with surgery result over timeat three examinations during Follow-Up (3 months postop, 1 year postop, 3 years postop)Patient is asked for satisfaction with surgery result with a 4-point scale: very satisfied, satisfied, unsatisfied, very unsatisfied
Radiologic Evaluation: Cup Inclination over timeimmediately postoperative, 3 months, 12 months and 3 years postoperativeInclination is the orientation of the cup in the coronal plane. The target acetabular cup inclination is a safe zone between 30-50° abduction (assessed on antero-posterior (ap) x-rays of the hip). The comparison of the intraoperatively achieved inclination and the inclination at different follow-up examinations allows prediction on longterm success.
Radiologic Evaluation: center of rotationimmediately postoperative, 3 months, 12 months and 3 years postoperativeCentre of Rotation (CoR) is defined as the zero position for the measurement of potential cup migration. Horizontal: Distance of CoR to ipsilateral teardrop; Vertical: Distance CoR to Inter-teardrop line; The comparison of the intraoperatively center of rotation and the center of rotation at different follow-up examinations allows prediction on longterm success.
Radiologic Evaluation: Radiolucencies around the cupover follow-up period 3 months, 12 months and 3 years postoperativeBony Osseointegration or conspicuous features of the cup are assessed on anterior-posterior and lateral x-rays of the cup and will be analysed according to the zones defined by Charnley. Charnley zones of the acetabular component are distinct zones used in assessment of aseptic loosening in total hip joint replacements. The radiolucencies are categorized to none, less than or equal to 2mm and more than 2 mm
Radiological Outcome: Heterotopic Ossificationover follow-up period 3 months, 12 months and 3 years postoperativeBrooker classification divides heterotopic ossifications that form following total hip replacement to four classes. Class I: islands of bone within soft tissues around hip; Class II: bone spurs in pelvis or proximal end of femur leaving ≥1 cm between the opposing bone surfaces; Class III: bone spurs that extend from pelvis or the proximal end of femur, which reduce the space between the opposing bone surfaces to \<1cm; Class IV: ankylosis of the hip on x-ray

Countries

Czechia

Contacts

Primary ContactLutz Dreyer, Dr.
info@aesculap.de+49746195
Backup ContactStefan Maenz, Dr.
info@aesculap.de+49746195

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026